USD 29.18 billion
Pharmaceutical Intermediates Market Size, Share, Growth Analysis, By Product (Chemical Intermediates, Bulk Drug Intermediates), By Category (Branded Drug Intermediates, Generic Drug Intermediates), By Application (Analgesics, Anti-Inflammatory Drug), By End User (Biotech And Pharma Companies, Research Laboratory), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35I2111 |
Region:
Global |
Published Date: December, 2024
Pages:
157
|Tables:
65
|Figures:
75
Pharmaceutical Intermediates Market Insights
Pharmaceutical Intermediates Market size was valued at USD 32.53 Billion in 2023 and is poised to grow from USD 34.58 Billion in 2024 to USD 56.37 Billion by 2032, growing at a CAGR of 6.30% during the forecast period (2025-2032).
Pharmaceutical intermediates are drugs that are used as raw materials in the manufacture of bulk drugs. They are commonly used to refer to the material formed during the synthesis of the active pharmaceutical ingredient (API) prior to the processing of the API. These are usually made from high-quality basic ingredients. The intermediates are widely used in the pharmaceutical and cosmetic industries. The global market is developing due to the increasing demand in these industries. These are widely used for research and development in the pharmaceutical industry. Pharmaceutical intermediates are produced using basic materials such as coal tar or petroleum to make pesticides, drugs, resins, additives, plasticizers, and other products. However, various intermediate products can be produced during organic synthesis and used to make various drugs.
Increasing production of active pharmaceutical ingredients is driving global pharmaceutical intermediates market. The growing trend of high-tech therapies with advanced delivery systems and the development of personalized and customized medicines are increasing the demand for active pharmaceutical ingredients worldwide. The high cost associated with the acquisition of biopharmaceutical drugs is a major factor hampering the growth of global market. Also, the high capital investment required for the production of APIs is a major restraining factor that may hamper market growth. The introduction of new technologies in the pharmaceutical industry for manufacturing various drugs, as well as increased investment in research activities, is expected to provide significant growth opportunities for the market in the coming years.
US Pharmaceutical Intermediates Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
Largest Segment
Bulk drug intermediates
Fastest Growth
Custom intermediates
Growth Rate
7.1% CAGR
Global pharmaceutical intermediates market, 2022-2030 ($ Bn)
Country Share for North America Region- 2022 (%)
To get more reports on the above market click here to Buy The Report
Pharmaceutical Intermediates Market Segmental Analysis
Global Pharmaceutical Intermediates Market is segmented by product, category, application, end user and region. Based on product, the market is segmented into chemical intermediates, bulk drug intermediates, chiral intermediates, achiral intermediates and custom intermediates. Based on category, the market is segmented into branded drug intermediates and generic drug intermediates. Based on application, the market is segmented into analgesics, anti-inflammatory drug, cardiovascular drugs, anti-diabetic drugs, antimicrobial drugs, anti-cancer drugs and others. Based on end user, the market is segmented into biotech and pharma companies, research laboratory and CMOS/CROS. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Pharmaceutical Intermediates Market Analysis by Product
On the basis of product, global pharmaceutical intermediates market is segmented into chemical intermediates, bulk drug intermediates and custom intermediates. Based on product, the bulk drug intermediates segment accounted for the largest revenue share. Bulk drug intermediates are widely used in the production of active pharmaceutical ingredients (API). API is the key ingredient used in the production of drugs that gives the targeted therapeutic effect. Also, government initiatives to promote and develop bulk drug parks are expected to drive the growth of this segment.
Custom intermediate is expected to be the fastest-growing segment during the forecast period. Custom drug intermediates are the customization of specific molecules to a specific amount to achieve a desired therapeutic effect or outcome. This segment is gradually gaining popularity in the market.
Pharmaceutical Intermediates Market Analysis by Application
On the basis of application, global pharmaceutical intermediates market is segmented into, analgesics, anti-inflammatory drug, cardiovascular drugs, anti-diabetic drugs and anti-cancer drugs. The analgesics segment accounted for around 30% of global pharmaceutical intermediates market and is expected to maintain its dominance during the forecast period. Analgesics are frequently used to relieve pain. The increased incidence of chronic diseases such as arthritis, cancer, and cardiovascular disease is driving this segment.
The anti-cancer drugs are expected to grow at the fastest rate during the forecast period. This is due to the rising incidence of cancer among the global population. According to the International Agency for Research on Cancer, there will be around 19.3 million new cancer cases and 10 million cancer deaths worldwide in 2020. Therefore, this segment is expected to be the fastest-growing segment.
Global pharmaceutical intermediates market size, by product, 2022 (%)
To get detailed analysis on other segments, Request For Free Sample Report
Pharmaceutical Intermediates Market Regional Insights
On the basis of region, global pharmaceutical intermediates market is divided into North America, Europe, Asia Pacific, Latin America, and MEA. North America dominated the global pharmaceutical intermediates market and is expected to maintain its dominance during the forecast period. North America is dominating the market due to the presence of various pharmaceutical companies, research centres, and laboratories, and rapidly growing CMOs & CROs in the US and Canada. Also, rising investments by the government and private players to boost the growth of the market.
Asia Pacific is expected to be the most competitive market during the forecast period. Increasing investment by market players to set up manufacturing facilities in countries such as China, India, Japan, South Korea, and Singapore is fuelling the growth of the pharmaceutical intermediates market over the forecast period due to the easy and cheap availability of product ingredients and favourable government policies.
Global pharmaceutical intermediates market, by geography, 2022-2030
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Pharmaceutical Intermediates Market Dynamics
Pharmaceutical Intermediates Market Driver
Increasing Incidence of Chronic Diseases
- The constantly increasing incidences of chronic diseases, as well as the aging population worldwide, are major factors that are expected to increase the need for drug formulations for the management of chronic diseases. According to the World Health Organization (WHO), the incidence of diabetes has increased from 108.0 million in 1980 to 422.0 million in 2014, and this number continues to rise. Also, according to the World Health Organization (WHO), the incidence of chronic diseases is expected to increase by 57% by 2020, indicating that a significant percentage of the population is suffering from chronic diseases. All these factors are driving the growth of the market during the forecast period.
Increasing Investments in Manufacturing
- Leading pharmaceutical companies in the pharmaceutical intermediates market have announced their intentions to invest in manufacturing facilities for various reasons, including increasing pharmaceutical intermediate production capacity, reducing corporate tax rates, and expanding their global footprint and presence in emerging economies. In July 2018, Pfizer invested USD 465.0 million to build a sterile injectable plant in Portage, Michigan. This is part of its earlier announcement in 2018 of plans to invest approximately USD 5 billion in US-based capital projects as a result of the country's recent corporate tax reforms. These factors will drive the expansion of the market during the forecast period.
Pharmaceutical Intermediates Market Restraint
High Cost Associated With The Acquisition Of Biopharmaceutical Drugs
- The high cost associated with the acquisition of biopharmaceutical drugs is a major factor hampering the growth of global pharmaceutical intermediates market. Also, the high capital investment required for the production of APIs is a major restraining factor that may hamper market growth.
Request Free Customization of this report to help us to meet your business objectives.
Pharmaceutical Intermediates Market Competitive Landscape
Global pharmaceutical intermediates market is highly competitive with the presence of local as well as global companies. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of global pharmaceutical intermediates market.
Pharmaceutical Intermediates Market Top Player's Company Profiles
- BASF SE (Germany)
- Sanofi SA (France)
- Thermo Fisher Scientific Inc. (US)
- Merck KGaA (Germany)
- Dishman Carbogen Amcis Ltd. (India)
- Evonik Industries AG (Germany)
- Arkema Inc. (France)
- Lonza Group AG (Switzerland)
- Wuxi AppTec Co., Ltd. (China)
- Aurobindo Pharma Limited (India)
- Lianhe Chemical Technology Co., Ltd. (China)
- Cambrex Corporation (US)
- Vertellus Holdings LLC (US)
- Hovione LLC (Portugal)
- Hikal Ltd. (India)
- Codexis Inc. (US)
- Aceto Corporation (US)
- Interchem Corporation (US)
- Midas Pharma GmbH (Germany)
- Arbiom (US)
Pharmaceutical Intermediates Market Recent Developments
- In February 2022, the Food and Drug Administration (FDA) approved Mylan Pharmaceuticals Inc., Vitaris Inc., has given the green light for an Abbreviated New Drug Application (ANDA) for Cyclosporine Ophthalmic Emulsion 0.05%. Allergan Restasis is the first generic version to treat dry eye disease.
- In February 2022, Cordenpharma purchased three manufacturing facilities from Vifor Pharma. These facilities will eventually be named Corden Pharma Friborg SA in Switzerland (with a branch in Ettingen) and Corden Pharma Lisbon SA in Portugal.
Pharmaceutical Intermediates Key Market Trends
- The cost of heart disease to the nation's health care system is increasing. A key trend in the pharmaceutical intermediates market is the rise in chronic cardiovascular conditions such as heart failure and coronary artery disease. According to a paper published in July 2020 in the Curious Journal of Medical Science, ischemic heart disease (IHD) is the leading cause of death worldwide. Ischemic heart disease affects about 126 million people globally. It is expected that by 2030, there will be more than 1,845 cases of ischemic heart disease per 100,000 persons worldwide.
Pharmaceutical Intermediates Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our business information services team that collects, collates, co-relates, and analyses the data collected by means of primary exploratory research backed by the robust secondary desk research.
According to our global pharmaceutical intermediates market analysis, on the basis of product segmentation, the bulk drug intermediates segment accounted for the largest revenue share. By application segment, the analgesics segment accounted for around 30% of global market and is expected to maintain its dominance during the forecast period. North America dominated the global market and is expected to maintain its dominance during the forecast period. The rise in chronic cardiovascular conditions such as heart failure and coronary artery disease is a major trend in global market. However, the high cost associated with the acquisition of biopharmaceutical drugs is a major factor hampering the growth of global market.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 32.53 Billion |
| Market size value in 2032 | USD 56.37 Billion |
| Growth Rate | 6.30% |
| Base year | 2024 |
| Forecast period | 2025-2032 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Pharmaceutical Intermediates Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Pharmaceutical Intermediates Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Pharmaceutical Intermediates Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Pharmaceutical Intermediates Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Pharmaceutical Intermediates Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Pharmaceutical Intermediates Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
